{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:29:24Z","timestamp":1793651364354,"version":"4.5.1"},"reference-count":303,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,11,2]],"date-time":"2027-11-02T00:00:00Z","timestamp":1825113600000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jchf.2026.103353","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:59:53Z","timestamp":1789415993000},"page":"103353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Skeletal Muscle Dysfunction in Heart Failure"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7067-1692","authenticated-orcid":false,"given":"Azariyas A.","family":"Challa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambarish","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Brubaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalane W.","family":"Kitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-0253","authenticated-orcid":false,"given":"Biykem","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5254-4067","authenticated-orcid":false,"given":"Dinesh K.","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2026.103353_bib1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1152\/japplphysiol.00049.2015","article-title":"Determinants of exercise intolerance in patients with heart failure and reduced or preserved ejection fraction","volume":"119","author":"Haykowsky","year":"2015","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib2","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacc.2021.07.014","article-title":"Exercise intolerance in older adults with heart failure with preserved ejection fraction: JACC State-of-the-Art Review","volume":"78","author":"Pandey","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib3","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.jacc.2019.01.072","article-title":"Exercise intolerance in patients with heart failure: JACC State-of-the-Art Review","volume":"73","author":"Del Buono","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib4","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1161\/01.CIR.0000055013.92097.40","article-title":"Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention","volume":"107","author":"Pi\u00f1a","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib5","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1016\/j.jacc.2021.01.030","article-title":"Cardiac rehabilitation for patients with heart failure: JACC expert panel","volume":"77","author":"Bozkurt","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2026141","article-title":"Physical rehabilitation for older patients hospitalized for heart failure","volume":"385","author":"Kitzman","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103353_bib7","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ejhf.1838","article-title":"Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials","volume":"23","author":"von Haehling","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib8","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2009.11.086","article-title":"Limited maximal exercise capacity in patients with chronic heart failure: partitioning the contributors","volume":"55","author":"Esposito","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib9","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11897-018-0408-6","article-title":"Impaired exercise tolerance in heart failure: role of skeletal muscle morphology and function","volume":"15","author":"Tucker","year":"2018","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jchf.2026.103353_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/CIRCULATIONAHA.117.029058","article-title":"Exercise intolerance in heart failure with preserved ejection fraction: diagnosing and ranking its causes using personalized O2 pathway analysis","volume":"137","author":"Houstis","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib11","doi-asserted-by":"crossref","first-page":"H1364","DOI":"10.1152\/ajpheart.00004.2014","article-title":"Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"306","author":"Kitzman","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib12","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jchf.2016.03.011","article-title":"Skeletal muscle mitochondrial content, oxidative capacity, and Mfn2 expression are reduced in older patients with heart failure and preserved ejection fraction and are related to exercise intolerance","volume":"4","author":"Molina","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib13","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamacardio.2023.0957","article-title":"Skeletal muscle mitochondrial respiration and exercise intolerance in patients with heart failure with preserved ejection fraction","volume":"8","author":"Scandalis","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.87.2.470","article-title":"Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure","volume":"87","author":"Wilson","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib15","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1172\/JCI115537","article-title":"Impaired skeletal muscle function in patients with congestive heart failure. Relationship to systemic exercise performance","volume":"88","author":"Minotti","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jchf.2026.103353_bib16","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.CIR.85.4.1364","article-title":"Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure","volume":"85","author":"Mancini","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib17","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib18","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/01.CIR.83.3.778","article-title":"Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure","volume":"83","author":"Mancini","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/CIRCRESAHA.125.325534","article-title":"Physiologic phenotyping of responses to exercise and activity in heart failure","volume":"137","author":"Lewis","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2026.103353_bib20","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1161\/01.CIR.0000041428.99427.06","article-title":"Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death","volume":"106","author":"Gitt","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib21","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/CIRCULATIONAHA.107.686576","article-title":"Development of a ventilatory classification system in patients with heart failure","volume":"115","author":"Arena","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7570\/jomes22025","article-title":"Assessment of muscle quantity, quality and function","volume":"31","author":"Koo","year":"2022","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.jchf.2026.103353_bib23","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1002\/jcsm.13041","article-title":"The current use of ultrasound to measure skeletal muscle and its ability to predict clinical outcomes: a systematic review","volume":"13","author":"Casey","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib24","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/jcsm.12977","article-title":"Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer","volume":"13","author":"Tang","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib25","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2011.02.055","article-title":"Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction","volume":"58","author":"Haykowsky","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIRCHEARTFAILURE.114.001825","article-title":"Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction","volume":"8","author":"Dhakal","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib27","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCULATIONAHA.123.065134","article-title":"Cardiac and metabolic effects of dapagliflozin in heart failure with preserved ejection fraction: the CAMEO-DAPA trial","volume":"148","author":"Borlaug","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib28","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1161\/CIRCULATIONAHA.122.061828","article-title":"Challenging the hemodynamic hypothesis in heart failure with preserved ejection fraction: is exercise capacity limited by elevated pulmonary capillary wedge pressure?","volume":"147","author":"Sarma","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib29","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1001\/jama.2018.14852","article-title":"Effect of inorganic nitrite vs placebo on exercise capacity among patients with heart failure with preserved ejection fraction: the INDIE-HFpEF randomized clinical trial","volume":"320","author":"Borlaug","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2026.103353_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.mayocp.2023.08.031","article-title":"Inorganic nitrite to amplify the benefits and tolerability of exercise training in heart failure with preserved ejection fraction: the INABLE-training trial","volume":"99","author":"Borlaug","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jchf.2026.103353_bib31","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0140-6736(22)00016-2","article-title":"Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial","volume":"399","author":"Shah","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2026.103353_bib32","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/0002-9149(79)90368-0","article-title":"Effect of isosorbide dinitrate on response to submaximal and maximal exercise in patients with congestive heart failure","volume":"43","author":"Franciosa","year":"1979","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib33","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.jacc.2023.02.012","article-title":"Supervised exercise training for chronic heart failure with preserved ejection fraction: a scientific statement from the American Heart Association and American College of Cardiology","volume":"81","author":"Sachdev","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCHEARTFAILURE.114.001615","article-title":"Exercise training in patients with heart failure and preserved ejection fraction: meta-analysis of randomized control trials","volume":"8","author":"Pandey","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib35","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jacc.2012.02.055","article-title":"Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction","volume":"60","author":"Haykowsky","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/PHM.0000000000000312","article-title":"Aerobic interval training elicits different hemodynamic adaptations between heart failure patients with preserved and reduced ejection fraction","volume":"95","author":"Fu","year":"2016","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.jchf.2026.103353_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/2047487312469477","article-title":"One year of high-intensity interval training improves exercise capacity, but not left ventricular function in stable heart transplant recipients: a randomised controlled trial","volume":"21","author":"Rustad","year":"2014","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib38","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/hrt.2003.025684","article-title":"Exercise capacity and cardiac function assessed by tissue Doppler imaging in chronic heart failure","volume":"90","author":"Witte","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.jchf.2026.103353_bib39","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/01.CIR.91.2.559","article-title":"Exercise intolerance in heart failure. Importance of skeletal muscle","volume":"91","author":"Wilson","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib40","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004129","article-title":"Fatigability, exercise intolerance, and abnormal skeletal muscle energetics in heart failure","volume":"10","author":"Weiss","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib41","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ejhf.239","article-title":"Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle","volume":"17","author":"Bowen","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib42","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1161\/01.CIR.85.5.1751","article-title":"Alterations of skeletal muscle in chronic heart failure","volume":"85","author":"Drexler","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007198","article-title":"Skeletal muscle function, structure, and metabolism in patients with heart failure with reduced ejection fraction and heart failure with preserved ejection fraction","volume":"13","author":"Bekfani","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib44","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1161\/01.CIR.80.5.1338","article-title":"Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure","volume":"80","author":"Mancini","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib45","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/S0735-1097(99)00101-1","article-title":"Capillary density of skeletal muscle: a contributing mechanism for exercise intolerance in class II-III chronic heart failure independent of other peripheral alterations","volume":"33","author":"Duscha","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/CIRCHEARTFAILURE.110.958785","article-title":"Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial","volume":"3","author":"Kitzman","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","article-title":"Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF)","volume":"34","author":"F\u00fclster","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103353_bib48","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","article-title":"Wasting as independent risk factor for mortality in chronic heart failure","volume":"349","author":"Anker","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2026.103353_bib49","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/CIRCHEARTFAILURE.109.876433","article-title":"Mechanisms underlying skeletal muscle weakness in human heart failure: alterations in single fiber myosin protein content and function","volume":"2","author":"Miller","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib50","doi-asserted-by":"crossref","first-page":"4039","DOI":"10.1113\/jphysiol.2010.191957","article-title":"Chronic heart failure decreases cross-bridge kinetics in single skeletal muscle fibres from humans","volume":"588","author":"Miller","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrcardio.2017.51","article-title":"Muscle wasting and cachexia in heart failure: mechanisms and therapies","volume":"14","author":"von Haehling","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib52","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0735-1097(02)01736-9","article-title":"Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure","volume":"39","author":"Hambrecht","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib53","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1152\/japplphysiol.00545.2010","article-title":"Chronic heart failure reduces Akt phosphorylation in human skeletal muscle: relationship to muscle size and function","volume":"110","author":"Toth","year":"2011","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib54","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/01.RES.0000179580.72375.c2","article-title":"Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction","volume":"97","author":"Schulze","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2026.103353_bib55","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1002\/ehf2.13405","article-title":"Ubiquitin-proteasome-system and enzymes of energy metabolism in skeletal muscle of patients with HFpEF and HFrEF","volume":"8","author":"Adams","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib56","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/CIRCULATIONAHA.111.047381","article-title":"Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig exercise intervention in chronic heart failure and aging catabolism study","volume":"125","author":"Gielen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/jcsm.12488","article-title":"Divergent skeletal muscle mitochondrial phenotype between male and female patients with chronic heart failure","volume":"11","author":"Garnham","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib58","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1161\/01.CIR.103.17.2195","article-title":"Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure","volume":"103","author":"Dalla","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib59","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(98)00626-3","article-title":"Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance","volume":"33","author":"Adams","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib60","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/cvr\/cvaa127","article-title":"Inhibition of xanthine oxidase in the acute phase of myocardial infarction prevents skeletal muscle abnormalities and exercise intolerance","volume":"117","author":"Nambu","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2026.103353_bib61","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jacbts.2023.09.014","article-title":"Caloric restriction rejuvenates skeletal muscle growth in heart failure with preserved ejection fraction","volume":"9","author":"Espino-Gonzalez","year":"2024","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jchf.2026.103353_bib62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12872-016-0278-3","article-title":"Primary skeletal muscle myoblasts from chronic heart failure patients exhibit loss of anti-inflammatory and proliferative activity","volume":"16","author":"Sente","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jchf.2026.103353_bib63","doi-asserted-by":"crossref","first-page":"23823","DOI":"10.1074\/jbc.M112.449074","article-title":"Angiotensin II inhibits satellite cell proliferation and prevents skeletal muscle regeneration","volume":"288","author":"Yoshida","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jchf.2026.103353_bib64","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.CIR.81.2.518","article-title":"Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure","volume":"81","author":"Sullivan","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib65","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cardfail.2018.08.009","article-title":"Effects of endurance training on detrimental structural, cellular, and functional alterations in skeletal muscles of heart failure with preserved ejection fraction","volume":"24","author":"Bowen","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib66","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/nu15143108","article-title":"3 PUFA-enriched diet preserves skeletal muscle mitochondrial function and redox state and prevents muscle mass loss in mice with chronic heart failure","volume":"15","author":"Gortan Cappellari","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.jchf.2026.103353_bib67","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.jchf.2018.06.002","article-title":"Regional adipose distribution and its relationship to exercise intolerance in older obese patients who have heart failure with preserved ejection fraction","volume":"6","author":"Haykowsky","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib68","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.amjcard.2013.12.031","article-title":"Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"113","author":"Haykowsky","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib69","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0167-5273(02)00014-1","article-title":"Effect of exercise training on skeletal muscle fibre characteristics in men with chronic heart failure. Correlation between skeletal muscle alterations, cytokines and exercise capacity","volume":"83","author":"Larsen","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib70","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2010.03.077","article-title":"Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction","volume":"56","author":"Borlaug","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib71","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/j.healun.2011.08.020","article-title":"Skeletal muscle microcirculatory abnormalities are associated with exercise intolerance, ventilatory inefficiency, and impaired autonomic control in heart failure","volume":"30","author":"Manetos","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2026.103353_bib72","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jamda.2016.09.006","article-title":"Sarcopenia and endothelial function in patients with chronic heart failure: results from the studies investigating comorbidities aggravating heart failure (SICA-HF)","volume":"18","author":"Dos Santos","year":"2017","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jchf.2026.103353_bib73","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.2337\/dc07-0843","article-title":"Skeletal muscle deoxygenation after the onset of moderate exercise suggests slowed microvascular blood flow kinetics in type 2 diabetes","volume":"30","author":"Bauer","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jchf.2026.103353_bib74","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCHEARTFAILURE.109.868992","article-title":"Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function","volume":"3","author":"Erbs","year":"2010","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib75","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0735-1097(97)00015-6","article-title":"Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure","volume":"29","author":"Hambrecht","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib76","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00421-002-0615-3","article-title":"Changes in skeletal muscle myosin heavy chain isoform content during congestive heart failure","volume":"87","author":"Spangenburg","year":"2002","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib77","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1161\/01.RES.79.1.128","article-title":"Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity","volume":"79","author":"Simonini","year":"1996","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2026.103353_bib78","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0002-9149(87)90233-5","article-title":"31P nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with congestive heart failure","volume":"60","author":"Massie","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib79","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/oxfordjournals.eurheartj.a015386","article-title":"Skeletal muscle alterations in patients with chronic heart failure","volume":"18","author":"Schaufelberger","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103353_bib80","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ejhf.2407","article-title":"Exercise: a molecular tool to boost muscle growth and mitochondrial performance in heart failure?","volume":"24","author":"Nijholt","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0002-8703(98)70353-9","article-title":"Skeletal muscle myosin heavy chains in heart failure: correlation between magnitude of the isozyme shift, exercise capacity, and gas exchange measurements","volume":"135","author":"Vescovo","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2026.103353_bib82","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s42255-020-0258-x","article-title":"Metabolic communication during exercise","volume":"2","author":"Murphy","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.jchf.2026.103353_bib83","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/gerona\/gls196","article-title":"Skeletal muscle mitochondrial energetics are associated with maximal aerobic capacity and walking speed in older adults","volume":"68","author":"Coen","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jchf.2026.103353_bib84","first-page":"427","article-title":"Skeletal muscle mitophagy in chronic disease: implications for muscle oxidative capacity?","volume":"19","author":"Leermakers","year":"2016","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.jchf.2026.103353_bib85","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/jcsm.12988","article-title":"Involvement of Parkin-mediated mitophagy in the pathogenesis of chronic obstructive pulmonary disease-related sarcopenia","volume":"13","author":"Ito","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib86","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1475-097X.1996.tb00567.x","article-title":"Exercise capacity in heart failure patients: relative importance of heart and skeletal muscle","volume":"16","author":"Magnusson","year":"1996","journal-title":"Clin Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.yjmcc.2011.10.022","article-title":"Biphasic response of skeletal muscle mitochondria to chronic cardiac pressure overload - role of respiratory chain complex activity","volume":"52","author":"Schrepper","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib88","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1113\/jphysiol.2003.045104","article-title":"Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles","volume":"551","author":"Garnier","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib89","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.yjmcc.2009.02.009","article-title":"Altered expression of the adenine nucleotide translocase isoforms and decreased ATP synthase activity in skeletal muscle mitochondria in heart failure","volume":"46","author":"Rosca","year":"2009","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib90","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/ehf2.13329","article-title":"Multimodality assessment of heart failure with preserved ejection fraction skeletal muscle reveals differences in the machinery of energy fuel metabolism","volume":"8","author":"Zamani","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib91","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ehf2.13272","article-title":"Quantifying the relationship and contribution of mitochondrial respiration to systemic exercise limitation in heart failure","volume":"8","author":"Knuiman","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib92","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017091","article-title":"Unique transcriptome signature distinguishes patients with heart failure with myopathy","volume":"9","author":"Caspi","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2026.103353_bib93","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1161\/01.CIR.84.4.1597","article-title":"Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity","volume":"84","author":"Sullivan","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib94","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/euhj.1997.0727","article-title":"A non-invasive selective assessment of type I fibre mitochondrial function using 31P NMR spectroscopy. Evidence for impaired oxidative phosphorylation rate in skeletal muscle in patients with chronic heart failure","volume":"19","author":"van der Ent","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103353_bib95","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ehf2.12035","article-title":"Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure","volume":"2","author":"Doehner","year":"2015","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib96","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0735-1097(97)00185-X","article-title":"Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure","volume":"30","author":"Swan","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib97","doi-asserted-by":"crossref","first-page":"H1637","DOI":"10.1152\/ajpheart.01185.2009","article-title":"Oxidative stress impairs insulin signal in skeletal muscle and causes insulin resistance in postinfarct heart failure","volume":"300","author":"Ohta","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib98","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijcard.2008.07.004","article-title":"Reduced glucose transporter GLUT4 in skeletal muscle predicts insulin resistance in non-diabetic chronic heart failure patients independently of body composition","volume":"138","author":"Doehner","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib99","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1113\/jphysiol.2003.042648","article-title":"Insulin signalling and resistance in patients with chronic heart failure","volume":"550","author":"Kemppainen","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib100","doi-asserted-by":"crossref","first-page":"H598","DOI":"10.1152\/ajpheart.00250.2022","article-title":"Contribution of skeletal muscle-specific microRNA-133b to insulin resistance in heart failure","volume":"324","author":"Velasquez","year":"2023","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib101","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0735-1097(01)01460-7","article-title":"Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects","volume":"38","author":"Mettauer","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib102","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1161\/01.CIR.102.15.1847","article-title":"Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle","volume":"102","author":"De Sousa","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib103","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.012512","article-title":"Skeletal muscle quantity versus quality in heart failure: exercise intolerance and outcomes in older patients with HFpEF are related to abnormal skeletal muscle metabolism rather than age-related skeletal muscle loss","volume":"18","author":"Lewsey","year":"2025","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib104","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1249\/JES.0000000000000158","article-title":"The renin-angiotensin system and skeletal muscle","volume":"46","author":"Powers","year":"2018","journal-title":"Exerc Sport Sci Rev"},{"key":"10.1016\/j.jchf.2026.103353_bib105","doi-asserted-by":"crossref","first-page":"H1202","DOI":"10.1152\/ajpheart.00534.2011","article-title":"Angiotensin II-induced reduction in exercise capacity is associated with increased oxidative stress in skeletal muscle","volume":"302","author":"Inoue","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib106","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41374-019-0355-1","article-title":"Mitochondrial dysfunction\/NLRP3 inflammasome axis contributes to angiotensin II-induced skeletal muscle wasting via PPAR-\u03b3","volume":"100","author":"Liu","year":"2020","journal-title":"Lab Invest"},{"key":"10.1016\/j.jchf.2026.103353_bib107","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/CIRCRESAHA.114.305393","article-title":"Angiotensin II induces skeletal muscle atrophy by activating TFEB-mediated MuRF1 expression","volume":"117","author":"Du Bois","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2026.103353_bib108","doi-asserted-by":"crossref","first-page":"C634","DOI":"10.1152\/ajpcell.00372.2013","article-title":"Angiotensin II modulates mouse skeletal muscle resting conductance to chloride and potassium ions and calcium homeostasis via the AT1 receptor and NADPH oxidase","volume":"307","author":"Cozzoli","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib109","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.arcmed.2014.03.003","article-title":"Functional and structural alterations of cardiac and skeletal muscle mitochondria in heart failure patients","volume":"45","author":"Guzm\u00e1n","year":"2014","journal-title":"Arch Med Res"},{"key":"10.1016\/j.jchf.2026.103353_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113833","article-title":"Skeletal muscle mitochondrial remodeling in heart failure: an update on mechanisms and therapeutic opportunities","volume":"155","author":"Lv","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jchf.2026.103353_bib111","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13850","article-title":"Reduction in acetylation of superoxide dismutase 2 in skeletal muscle improves exercise capacity in mice with heart failure","volume":"16","author":"Masunaga","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib112","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/jcsm.12322","article-title":"Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure","volume":"9","author":"Tsuda","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib113","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1073\/pnas.1111308108","article-title":"Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production","volume":"108","author":"Jing","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jchf.2026.103353_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127172","article-title":"Sirtuin3 dysfunction is the key determinant of skeletal muscle insulin resistance by angiotensin II","volume":"10","author":"Macconi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2026.103353_bib115","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.yjmcc.2018.04.002","article-title":"Deficiency of aldose reductase exacerbates early pressure overload-induced cardiac dysfunction and autophagy in mice","volume":"118","author":"Baba","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib116","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/antiox7080102","article-title":"Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders","volume":"7","author":"Barrera","year":"2018","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jchf.2026.103353_bib117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/bi981794l","article-title":"Structural and kinetic determinants of aldehyde reduction by aldose reductase","volume":"38","author":"Srivastava","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.jchf.2026.103353_bib118","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1113\/JP272050","article-title":"Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by \u03b2-alanine transamination","volume":"594","author":"Blancquaert","year":"2016","journal-title":"J Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib119","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.015222","article-title":"Cardiospecific overexpression of ATPGD1 (carnosine synthase) increases histidine dipeptide levels and prevents myocardial ischemia reperfusion injury","volume":"9","author":"Zhao","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2026.103353_bib120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13395-024-00354-2","article-title":"Metabolic pathways for removing reactive aldehydes are diminished in the skeletal muscle during heart failure","volume":"14","author":"Chaudhari","year":"2024","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib121","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10741-016-9593-0","article-title":"Skeletal muscle inflammation and atrophy in heart failure","volume":"22","author":"Lavine","year":"2017","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jchf.2026.103353_bib122","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0735-1097(03)00848-9","article-title":"Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure","volume":"42","author":"Gielen","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib123","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.103.16.2055","article-title":"Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST)","volume":"103","author":"Deswal","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib124","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC State-of-the-Art Review","volume":"75","author":"Murphy","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib125","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.tem.2016.03.002","article-title":"Cytokine signaling in skeletal muscle wasting","volume":"27","author":"Zhou","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jchf.2026.103353_bib126","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.healun.2024.04.069","article-title":"Alterations in the sarcopenia index are associated with inflammation, gut, and oral microbiota among heart failure, left ventricular assist device, and heart transplant patients","volume":"43","author":"Yuzefpolskaya","year":"2024","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2026.103353_bib127","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0735-1097(98)00531-2","article-title":"Exercise intolerance in patients with chronic heart failure and increased expression of inducible nitric oxide synthase in the skeletal muscle","volume":"33","author":"Hambrecht","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib128","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1677\/joe.0.1810419","article-title":"Inflammation and nitric oxide production in skeletal muscle of type 2 diabetic patients","volume":"181","author":"Torres","year":"2004","journal-title":"J Endocrinol"},{"key":"10.1016\/j.jchf.2026.103353_bib129","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013591","article-title":"Pharmacological or genetic inhibition of iNOS prevents cachexia-mediated muscle wasting and its associated metabolism defects","volume":"13","author":"Sadek","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jchf.2026.103353_bib130","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeae082","article-title":"Impact of whole-body and skeletal muscle composition on peak oxygen uptake in heart failure: a systematic review and meta-analysis","volume":"4","author":"Schmid","year":"2024","journal-title":"Eur Heart J Open"},{"key":"10.1016\/j.jchf.2026.103353_bib131","doi-asserted-by":"crossref","first-page":"H1126","DOI":"10.1152\/ajpheart.00587.2025","article-title":"Mechanisms of exercise limitation in heart failure with preserved ejection fraction and obesity: a case of engine-chassis mismatch","volume":"329","author":"Foulkes","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib132","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/oby.70162","article-title":"Obesity and heart failure with preserved ejection fraction: a clinical nexus for exercise intolerance","volume":"34","author":"Pandit","year":"2026","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.jchf.2026.103353_bib133","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jacc.2025.06.055","article-title":"The adipokine hypothesis of heart failure with a preserved ejection fraction: a novel framework to explain pathogenesis and guide treatment","volume":"86","author":"Packer","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib134","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/ejhf.1926","article-title":"Prevalence and prognostic impact of the coexistence of multiple frailty domains in elderly patients with heart failure: the FRAGILE-HF cohort study","volume":"22","author":"Matsue","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib135","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/jcsm.12603","article-title":"Muscle wasting as an independent predictor of survival in patients with chronic heart failure","volume":"11","author":"von Haehling","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib136","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/eurjpc\/zwaa117","article-title":"Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction","volume":"28","author":"Konishi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib137","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/eurheartj\/ehab850","article-title":"Frailty and cardiovascular mortality in more than 3 million US veterans","volume":"43","author":"Shrauner","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103353_bib138","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/cvr\/cvae073","article-title":"Biological basis and treatment of frailty and sarcopenia","volume":"120","author":"Sato","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2026.103353_bib139","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.cmet.2017.04.021","article-title":"Age-associated loss of OPA1 in muscle impacts muscle mass, metabolic homeostasis, systemic inflammation, and epithelial senescence","volume":"25","author":"Tezze","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.jchf.2026.103353_bib140","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/jamacardio.2019.4150","article-title":"Sex differences in cardiometabolic traits and determinants of exercise capacity in heart failure with preserved ejection fraction","volume":"5","author":"Lau","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib141","doi-asserted-by":"crossref","first-page":"H11","DOI":"10.1152\/ajpheart.00254.2026","article-title":"Sex differences in the peripheral determinants of oxygen transport and utilization in patients with heart failure with preserved ejection fraction","volume":"331","author":"Hearon","year":"2026","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib142","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jchf.2019.01.004","article-title":"Sex differences in heart failure with preserved ejection fraction pathophysiology: a detailed invasive hemodynamic and echocardiographic analysis","volume":"7","author":"Beale","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib143","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1152\/japplphysiol.00153.2025","article-title":"Sex-based differences in peak oxygen uptake among individuals with heart failure: systematic review and meta-analysis","volume":"139","author":"Skow","year":"2025","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib144","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41569-024-00996-1","article-title":"Sex-related similarities and differences in responses to heart failure therapies","volume":"21","author":"Chyou","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib145","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1093\/eurheartj\/ehaa823","article-title":"Pathophysiologic importance of visceral adipose tissue in women with heart failure and preserved ejection fraction","volume":"42","author":"Sorimachi","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103353_bib146","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/ejhf.2563","article-title":"Sex and central obesity in heart failure with preserved ejection fraction","volume":"24","author":"Sorimachi","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib147","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2017.10.003","article-title":"17\u03b2-Estradiol directly lowers mitochondrial membrane microviscosity and improves bioenergetic function in skeletal muscle","volume":"27","author":"Torres","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.jchf.2026.103353_bib148","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mce.2014.01.002","article-title":"Estrogen and the female heart","volume":"389","author":"Knowlton","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jchf.2026.103353_bib149","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.124865","article-title":"Changes in body composition and weight during the menopause transition","volume":"4","author":"Greendale","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jchf.2026.103353_bib150","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.011471","article-title":"Sex differences in skeletal muscle pathology in patients with heart failure and reduced ejection fraction","volume":"17","author":"Wood","year":"2024","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib151","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/eurheartj\/ehag175","article-title":"Heart failure and preserved ejection fraction: pathophysiology, clinical assessment, and management of exercise intolerance","volume":"47","author":"Landsteiner","year":"2026","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2026.103353_bib152","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.5135","article-title":"SGLT2 inhibitors, functional capacity, and quality of life in patients with heart failure: a systematic review and meta-analysis","volume":"7","author":"Gao","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jchf.2026.103353_bib153","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00228-024-03660-2","article-title":"Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials involving 2624 patients","volume":"80","author":"Tanashat","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jchf.2026.103353_bib154","first-page":"VI56","article-title":"Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group","volume":"87","author":"Ziesche","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib155","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jchf.2023.07.010","article-title":"Short-term changes in peak VO","volume":"11","author":"Lorenzo","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib156","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jama.2020.26812","article-title":"Effect of high-intensity interval training, moderate continuous training, or guideline-based physical activity advice on peak oxygen consumption in patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"325","author":"Mueller","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2026.103353_bib157","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure with preserved ejection fraction: a randomized clinical trial","volume":"315","author":"Kitzman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2026.103353_bib158","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O'Connor","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2026.103353_bib159","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCHEARTFAILURE.113.001420","article-title":"Exercise training as therapy for heart failure: current status and future directions","volume":"8","author":"Fleg","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib160","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2009.457","article-title":"Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"Flynn","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2026.103353_bib161","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0735-1097(94)00568-B","article-title":"Physical training in patients with stable chronic heart failure: effects on cardiorespiratory fitness and ultrastructural abnormalities of leg muscles","volume":"25","author":"Hambrecht","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib162","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1161\/01.CIR.98.24.2709","article-title":"Regular physical exercise corrects endothelial dysfunction and improves exercise capacity in patients with chronic heart failure","volume":"98","author":"Hambrecht","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib163","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3390\/cells10081915","article-title":"Exercise training enhances angiogenesis-related gene responses in skeletal muscle of patients with chronic heart failure","volume":"10","author":"Tryfonos","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jchf.2026.103353_bib164","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1161\/01.CIR.0000165503.08661.E5","article-title":"Antioxidative effects of exercise training in patients with chronic heart failure: increase in radical scavenger enzyme activity in skeletal muscle","volume":"111","author":"Linke","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib165","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.lfs.2018.10.015","article-title":"Effects of different types of exercise on skeletal muscle atrophy, antioxidant capacity and growth factors expression following myocardial infarction","volume":"213","author":"Cai","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.jchf.2026.103353_bib166","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijcard.2016.03.071","article-title":"Akt\/mTOR pathway contributes to skeletal muscle anti-atrophic effect of aerobic exercise training in heart failure mice","volume":"214","author":"Bacurau","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib167","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14161","article-title":"Voluntary physical activity counteracts chronic heart failure progression affecting both cardiac function and skeletal muscle in the transgenic Tg\u03b1q\u221744 mouse model","volume":"7","author":"Bardi","year":"2019","journal-title":"Physiol Rep"},{"key":"10.1016\/j.jchf.2026.103353_bib168","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1152\/japplphysiol.00760.2012","article-title":"High-versus moderate-intensity aerobic exercise training effects on skeletal muscle of infarcted rats","volume":"114","author":"Moreira","year":"2013","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib169","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jacbts.2024.07.009","article-title":"Exercise therapy rescues skeletal muscle dysfunction and exercise intolerance in cardiometabolic HFpEF","volume":"9","author":"Quiriarte","year":"2024","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jchf.2026.103353_bib170","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2508286123","article-title":"Mitochondrial remodeling in skeletal muscle underlies exercise-induced reversal of age-associated functional decline in mice and humans","volume":"123","author":"Garc\u00eda-Dom\u00ednguez","year":"2026","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jchf.2026.103353_bib171","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1096\/fj.201600143RR","article-title":"Exercise conditioning in old mice improves skeletal muscle regeneration","volume":"30","author":"Joanisse","year":"2016","journal-title":"FASEB J"},{"key":"10.1016\/j.jchf.2026.103353_bib172","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.7150\/thno.43577","article-title":"Exercise protects proliferative muscle satellite cells against exhaustion via the Igfbp7-Akt-mTOR axis","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jchf.2026.103353_bib173","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009124","article-title":"Impact of different training modalities on molecular alterations in skeletal muscle of patients with heart failure with preserved ejection fraction: a substudy of the OptimEx trial","volume":"15","author":"Winzer","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib174","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13395-020-00237-2","article-title":"Exercise promotes satellite cell contribution to myofibers in a load-dependent manner","volume":"10","author":"Masschelein","year":"2020","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/apha.12317","article-title":"Oestrogen-dependent satellite cell activation and proliferation following a running exercise occurs via the PI3K signalling pathway and not IGF-1","volume":"212","author":"Mangan","year":"2014","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.jchf.2026.103353_bib176","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10741-024-10439-1","article-title":"Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities","volume":"30","author":"Vacca","year":"2025","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jchf.2026.103353_bib177","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13963","article-title":"Calorie restriction modulates the transcription of genes related to stress response and longevity in human muscle: the CALERIE study","volume":"22","author":"Das","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.jchf.2026.103353_bib178","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022930","article-title":"Pragmatic weight management program for patients with obesity and heart failure with preserved ejection fraction","volume":"10","author":"El Hajj","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jchf.2026.103353_bib179","article-title":"A randomized, controlled trial of resistance training added to caloric restriction plus aerobic exercise training in obese heart failure with preserved ejection fraction","volume":"16","author":"Brubaker","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib180","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.cardfail.2024.06.007","article-title":"Long-term changes in body composition and exercise capacity following calorie restriction and exercise training in older patients with obesity and heart failure with preserved ejection fraction","volume":"31","author":"Upadhya","year":"2025","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib181","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1152\/japplphysiol.00853.2006","article-title":"Lower extremity muscle size and strength and aerobic capacity decrease with caloric restriction but not with exercise-induced weight loss","volume":"102","author":"Weiss","year":"2007","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jchf.2026.103353_bib182","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1161\/CIRCHEARTFAILURE.113.000481","article-title":"Low-sodium DASH diet improves diastolic function and ventricular-arterial coupling in hypertensive heart failure with preserved ejection fraction","volume":"6","author":"Hummel","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108902","article-title":"Protective effects of extra virgin olive oil and exercise training on rat skeletal muscle against high-fat diet feeding","volume":"100","author":"Yeo","year":"2022","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jchf.2026.103353_bib184","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00394-012-0368-7","article-title":"Fish oil positively regulates anabolic signalling alongside an increase in whole-body gluconeogenesis in ageing skeletal muscle","volume":"52","author":"Kamolrat","year":"2013","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jchf.2026.103353_bib185","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3390\/nu14112221","article-title":"Effects of omega-3 supplementation alone and combined with resistance exercise on skeletal muscle in older adults: a systematic review and meta-analysis","volume":"14","author":"Cornish","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jchf.2026.103353_bib186","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jchf.2022.01.004","article-title":"1 year HIIT and omega-3 fatty acids to improve cardiometabolic risk in stage-a heart failure","volume":"10","author":"Hearon","year":"2022","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib187","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.125.013511","article-title":"Unsaturated fatty acids to improve cardiorespiratory fitness in patients with obesity-related heart failure with preserved ejection fraction: the UFA-Preserved2 randomized controlled crossover study","volume":"19","author":"Carbone","year":"2026","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib188","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/cells13060502","article-title":"Leucine supplementation prevents the development of skeletal muscle dysfunction in a rat model of HFpEF","volume":"13","author":"Alves","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jchf.2026.103353_bib189","doi-asserted-by":"crossref","first-page":"104E","DOI":"10.1016\/j.amjcard.2008.03.008","article-title":"Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure","volume":"101","author":"Aquilani","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib190","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/CIRCHEARTFAILURE.115.002073","article-title":"Supplementation of l-alanyl-l-glutamine and fish oil improves body composition and quality of life in patients with chronic heart failure","volume":"8","author":"Wu","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib191","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.3390\/ijms27062886","article-title":"Structural and metabolic remodeling of skeletal muscle in heart failure with reduced ejection fraction: a review: beyond the failing heart","volume":"27","author":"Chaudhari","year":"2026","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jchf.2026.103353_bib192","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00726-011-1190-x","article-title":"Beta-alanine (Carnosyn\u2122) supplementation in elderly subjects (60-80 years): effects on muscle carnosine content and physical capacity","volume":"43","author":"del Favero","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.jchf.2026.103353_bib193","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nut.2014.04.021","article-title":"Effects of oral administration of orodispersible levo-carnosine on quality of life and exercise performance in patients with chronic heart failure","volume":"31","author":"Lombardi","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/j.jchf.2026.103353_bib194","article-title":"Ketone bodies in cardiovascular disease: the vasculature as a therapeutic target","volume":"10","author":"Challa","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jchf.2026.103353_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchf.2025.03.002","article-title":"Crossover trial of exogenous ketones on cardiometabolic endpoints in heart failure with preserved ejection fraction","volume":"13","author":"Selvaraj","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib196","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103353_bib197","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103353_bib198","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103353_bib199","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41591-023-02526-x","article-title":"Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial","volume":"29","author":"Borlaug","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2026.103353_bib200","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41591-024-03374-z","article-title":"Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial","volume":"31","author":"Borlaug","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2026.103353_bib201","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/HCO.0000000000001117","article-title":"Beyond weight loss: the emerging role of incretin-based treatments in cardiometabolic HFpEF","volume":"39","author":"Capone","year":"2024","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib202","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jacbts.2023.05.012","article-title":"The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF","volume":"8","author":"Withaar","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jchf.2026.103353_bib203","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/cvr\/cvaa256","article-title":"The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction","volume":"117","author":"Withaar","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2026.103353_bib204","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154044","article-title":"Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents","volume":"103","author":"Gurjar","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/j.jchf.2026.103353_bib205","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.2147\/DDDT.S381546","article-title":"An effective glucagon-like peptide-1 receptor agonists, semaglutide, improves sarcopenic obesity in obese mice by modulating skeletal muscle metabolism","volume":"16","author":"Ren","year":"2022","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jchf.2026.103353_bib206","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/jcsm.12434","article-title":"Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy","volume":"10","author":"Hong","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib207","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.metabol.2014.05.008","article-title":"Liraglutide enhances glucose transporter 4 translocation via regulation of AMP-activated protein kinase signaling pathways in mouse skeletal muscle cells","volume":"63","author":"Li","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.jchf.2026.103353_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111472","article-title":"Effect of GLP-1 receptor agonist, liraglutide, on muscle in spontaneously diabetic torii fatty rats","volume":"539","author":"Yamada","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jchf.2026.103353_bib209","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.70147","article-title":"Muscle loss in obesity therapy as a therapeutic target: trial design and endpoints for regulatory discussions","volume":"16","author":"von Haehling","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib210","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103353_bib211","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103353_bib212","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S2213-8587(25)00092-0","article-title":"Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial","volume":"13","author":"Coskun","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jchf.2026.103353_bib213","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S2213-8587(25)00027-0","article-title":"Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial","volume":"13","author":"Sattar","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jchf.2026.103353_bib214","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/dom.70141","article-title":"Impact of semaglutide on fat mass, lean mass and muscle function in patients with obesity: the SEMALEAN study","volume":"28","author":"Alissou","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jchf.2026.103353_bib215","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae164","article-title":"Fundamental body composition principles provide context for fat-free and skeletal muscle loss with GLP-1 RA treatments","volume":"8","author":"Tinsley","year":"2024","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.jchf.2026.103353_bib216","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.cmet.2025.07.004","article-title":"Unexpected effects of semaglutide on skeletal muscle mass and force-generating capacity in mice","volume":"37","author":"Karasawa","year":"2025","journal-title":"Cell Metab"},{"key":"10.1016\/j.jchf.2026.103353_bib217","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2147\/DMSO.S425642","article-title":"GLP-1RA liraglutide and semaglutide improves obesity-induced muscle atrophy via SIRT1 pathway","volume":"16","author":"Xiang","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jchf.2026.103353_bib218","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2024.101880","article-title":"Antibody blockade of activin type II receptors preserves skeletal muscle mass and enhances fat loss during GLP-1 receptor agonism","volume":"80","author":"Nunn","year":"2024","journal-title":"Mol Metab"},{"key":"10.1016\/j.jchf.2026.103353_bib219","article-title":"Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans","volume":"7","author":"Langer","year":"2026","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jchf.2026.103353_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172810","article-title":"Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure","volume":"866","author":"Nambu","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jchf.2026.103353_bib221","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231910989","article-title":"Empagliflozin preserves skeletal muscle function in a HFpEF rat model","volume":"23","author":"Winzer","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jchf.2026.103353_bib222","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/antiox14060647","article-title":"Impact of SGLT2i on cardiac remodeling and the soleus muscle of infarcted rats","volume":"14","author":"Souza","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jchf.2026.103353_bib223","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ejhf.3192","article-title":"Sodium-glucose cotransporter 2 inhibitors influence skeletal muscle pathology in patients with heart failure and reduced ejection fraction","volume":"26","author":"Wood","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib224","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1376645","article-title":"Impact of sodium-glucose cotransporter-2 inhibitor use on peak VO","volume":"11","author":"Desai","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jchf.2026.103353_bib225","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010633","article-title":"Effect of dapagliflozin on 6-minute walk distance in heart failure with preserved ejection fraction: preserved-HF","volume":"16","author":"Lewis","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib226","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/CIRCULATIONAHA.123.065061","article-title":"Effect of dapagliflozin versus placebo on symptoms and 6-minute walk distance in patients with heart failure: the DETERMINE randomized clinical trials","volume":"149","author":"McMurray","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib227","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1002\/ehf2.13430","article-title":"Does renin-angiotensin system inhibition have impacts on muscle mass and bone mineral density in heart failure patients?","volume":"8","author":"Katano","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib228","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1530\/JME-21-0033","article-title":"20-Hydroxyecdysone activates the protective arm of the RAAS via the MAS receptor","volume":"68","author":"Lafont","year":"2021","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.jchf.2026.103353_bib229","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/CS20140215","article-title":"Angiotensin-(1-7) decreases skeletal muscle atrophy induced by angiotensin II through a Mas receptor-dependent mechanism","volume":"128","author":"Cisternas","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jchf.2026.103353_bib230","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jcsm.13326","article-title":"BIO101 stimulates myoblast differentiation and improves muscle function in adult and old mice","volume":"15","author":"Serova","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib231","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.13750","article-title":"BIO101 in sarcopenic seniors at risk of mobility disability: results of a double-blind randomised interventional phase 2b trial","volume":"16","author":"Fielding","year":"2025","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib232","doi-asserted-by":"crossref","first-page":"16042","DOI":"10.1073\/pnas.1514250112","article-title":"Musclin is an activity-stimulated myokine that enhances physical endurance","volume":"112","author":"Subbotina","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jchf.2026.103353_bib233","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1172\/JCI64526","article-title":"Natriuretic peptides enhance the oxidative capacity of human skeletal muscle","volume":"122","author":"Engeli","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jchf.2026.103353_bib234","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.124.012350","article-title":"Musclin counteracts skeletal muscle dysfunction and exercise intolerance in heart failure with preserved ejection fraction","volume":"18","author":"Saw","year":"2025","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib235","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ejhf.2093","article-title":"Peripheral and pulmonary effects of inorganic nitrite during exercise in heart failure with preserved ejection fraction","volume":"23","author":"Reddy","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib236","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jchf.2015.12.013","article-title":"One week of daily dosing with beetroot juice improves submaximal endurance and blood pressure in older patients with heart failure and preserved ejection fraction","volume":"4","author":"Eggebeen","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib237","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1161\/CIRCHEARTFAILURE.115.002141","article-title":"Acute dietary nitrate intake improves muscle contractile function in patients with heart failure: a double-blind, placebo-controlled, randomized trial","volume":"8","author":"Coggan","year":"2015","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib238","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cardfail.2017.09.004","article-title":"Dietary nitrate increases VO","volume":"24","author":"Coggan","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib239","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1001\/jamacardio.2024.4417","article-title":"Potassium nitrate in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"10","author":"Zamani","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib240","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2023.101208","article-title":"The inorganic NItrate and eXercise performance in heart failure (iNIX-HF) phase II clinical trial: rationale and study design","volume":"36","author":"Coggan","year":"2023","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.jchf.2026.103353_bib241","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103353_bib242","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12872-025-04477-2","article-title":"Efficacy of vericiguat in patients with chronic heart failure and reduced ejection fraction: a prospective observational study","volume":"25","author":"Zhan","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jchf.2026.103353_bib243","article-title":"Soluble guanylate cyclase stimulator vericiguat alleviates skeletal muscle injury and exercise capacity decline in ApoE","volume":"245","author":"Li","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jchf.2026.103353_bib244","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1001\/jama.2020.15922","article-title":"Effect of vericiguat vs placebo on quality of life in patients with heart failure and preserved ejection fraction: the VITALITY-HFpEF randomized clinical trial","volume":"324","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2026.103353_bib245","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.008755","article-title":"Testosterone, hypogonadism, and heart failure","volume":"15","author":"Di Lodovico","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib246","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.jacc.2009.04.078","article-title":"Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study","volume":"54","author":"Caminiti","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib247","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103353_bib248","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib249","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(13)70055-X","article-title":"Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial","volume":"14","author":"Dobs","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jchf.2026.103353_bib250","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1210\/en.2005-0572","article-title":"Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats","volume":"146","author":"Gao","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.jchf.2026.103353_bib251","doi-asserted-by":"crossref","first-page":"e1252","DOI":"10.1210\/clinem\/dgae814","article-title":"GH therapy in chronic heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"110","author":"Theodorakis","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jchf.2026.103353_bib252","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jchf.2024.11.017","article-title":"Growth hormone replacement therapy in heart failure with reduced ejection fraction: a randomized, double-blind, placebo-controlled trial","volume":"13","author":"Marra","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib253","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jchf.2026.103353_bib254","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/jcsm.12254","article-title":"Acylated ghrelin treatment normalizes skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rat chronic heart failure","volume":"8","author":"Barazzoni","year":"2017","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026865","article-title":"Ghrelin and its analogues, BIM-28131 and BIM-28125, improve body weight and regulate the expression of MuRF-1 and MAFbx in a rat heart failure model","volume":"6","author":"Palus","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2026.103353_bib256","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1161\/01.CIR.0000149746.62908.BB","article-title":"Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure","volume":"110","author":"Nagaya","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib257","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s13539-013-0125-7","article-title":"The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats","volume":"5","author":"P\u00f6tsch","year":"2014","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib258","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/jcsm.12126","article-title":"Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)","volume":"7","author":"Stewart Coats","year":"2016","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib259","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1128\/MCB.01307-13","article-title":"An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy","volume":"34","author":"Lach-Trifilieff","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jchf.2026.103353_bib260","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.33457","article-title":"Effect of bimagrumab vs placebo on body fat mass among adults with type 2 diabetes and obesity: a phase 2 randomized clinical trial","volume":"4","author":"Heymsfield","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jchf.2026.103353_bib261","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41591-026-04204-0","article-title":"Bimagrumab plus semaglutide alone or in combination for the treatment of obesity: a randomized phase 2 trial","volume":"32","author":"Heymsfield","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2026.103353_bib262","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000209151","article-title":"Safety and efficacy of apitegromab in patients with spinal muscular atrophy types 2 and 3: the phase 2 TOPAZ study","volume":"102","author":"Crawford","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.jchf.2026.103353_bib263","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/s41591-026-04440-4","article-title":"Apitegromab for lean mass preservation during tirzepatide-induced weight loss: a randomized, double-blind, placebo-controlled phase 2 trial","volume":"32","author":"Pratley","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2026.103353_bib264","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251910273","article-title":"Taldefgrobep alfa and the phase 3 RESILIENT trial in spinal muscular atrophy","volume":"25","author":"Servais","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jchf.2026.103353_bib265","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1038\/s41467-025-59485-9","article-title":"GDF8 and activin A blockade protects against GLP-1-induced muscle loss while enhancing fat loss in obese male mice and non-human primates","volume":"16","author":"Mastaitis","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.jchf.2026.103353_bib266","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jchf.2014.06.008","article-title":"The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial","volume":"2","author":"Mortensen","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib267","article-title":"Coenzyme Q10 for heart failure","volume":"2","author":"Al Saadi","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jchf.2026.103353_bib268","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/HYPERTENSIONAHA.117.10787","article-title":"Chronic supplementation with a mitochondrial antioxidant (MitoQ) improves vascular function in healthy older adults","volume":"71","author":"Rossman","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.jchf.2026.103353_bib269","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116020","article-title":"Therapeutic effects of the combination of moderate-intensity endurance training and MitoQ supplementation in rats with isoproterenol-induced myocardial injury: the role of mitochondrial fusion, fission, and mitophagy","volume":"170","author":"Rostamzadeh","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jchf.2026.103353_bib270","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ehjci\/jeaf310","article-title":"A double-blind, randomized placebo-controlled trial examining the effect of MitoQ on myocardial energetics in patients with dilated cardiomyopathy","volume":"27","author":"Halliday","year":"2026","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2026.103353_bib271","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jamacardio.2025.0103","article-title":"Novel controlled metabolic accelerator for obesity-related HFpEF: the HuMAIN-HFpEF randomized clinical trial","volume":"10","author":"Pandey","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2026.103353_bib272","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1681\/ASN.2012121216","article-title":"The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin","volume":"24","author":"Birk","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jchf.2026.103353_bib273","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/ehf2.12408","article-title":"Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failure","volume":"6","author":"Sabbah","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib274","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cardfail.2020.02.001","article-title":"Effects of elamipretide on left ventricular function in patients with heart failure with reduced ejection fraction: the PROGRESS-HF phase 2 trial","volume":"26","author":"Butler","year":"2020","journal-title":"J Card Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib275","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44279","article-title":"Effect of urolithin A supplementation on muscle endurance and mitochondrial health in older adults: a randomized clinical trial","volume":"5","author":"Liu","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jchf.2026.103353_bib276","article-title":"Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults","volume":"3","author":"Singh","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jchf.2026.103353_bib277","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004373","article-title":"Interleukin-1 blockade in recently decompensated systolic heart failure: results from REDHART (recently decompensated heart failure anakinra response trial)","volume":"10","author":"Van Tassell","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib278","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.125.013546","article-title":"Resolution of systemic inflammation in patients with recently decompensated heart failure with reduced ejection fraction with and without Interleukin-1 blockade by anakinra","volume":"19","author":"Van Tassell","year":"2026","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib279","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107761","article-title":"Current anti-inflammatory strategies for treatment of heart failure: from innate to adaptive immunity","volume":"216","author":"Taylor","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jchf.2026.103353_bib280","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the treatment of cancer cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2026.103353_bib281","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2008.06.051","article-title":"AMPK and PPARdelta agonists are exercise mimetics","volume":"134","author":"Narkar","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jchf.2026.103353_bib282","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41573-019-0019-2","article-title":"AMP-activated protein kinase: the current landscape for drug development","volume":"18","author":"Steinberg","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jchf.2026.103353_bib283","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/hmg\/ddac222","article-title":"Combinatorial treatment with exercise and AICAR potentiates the rescue of myotonic dystrophy type 1 mouse muscles in a sex-specific manner","volume":"32","author":"Misquitta","year":"2023","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jchf.2026.103353_bib284","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.molmet.2015.06.002","article-title":"The AMPK activator R419 improves exercise capacity and skeletal muscle insulin sensitivity in obese mice","volume":"4","author":"Marcinko","year":"2015","journal-title":"Mol Metab"},{"key":"10.1016\/j.jchf.2026.103353_bib285","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aeb3338","article-title":"Ampk alpha2 T172 activation dictates exercise performance and energy transduction in skeletal muscle","volume":"12","author":"Montalvo","year":"2026","journal-title":"Sci Adv"},{"key":"10.1016\/j.jchf.2026.103353_bib286","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s42003-021-02837-0","article-title":"AMPK activator O304 improves metabolic and cardiac function, and exercise capacity in aged mice","volume":"4","author":"Ericsson","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.jchf.2026.103353_bib287","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1002\/ejhf.1656","article-title":"A randomised, double-blind, placebo-controlled trial of metformin on myocardial efficiency in insulin-resistant chronic heart failure patients without diabetes","volume":"22","author":"Larsen","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib288","doi-asserted-by":"crossref","first-page":"H842","DOI":"10.1152\/ajpheart.00455.2016","article-title":"Resveratrol improves exercise performance and skeletal muscle oxidative capacity in heart failure","volume":"312","author":"Sung","year":"2017","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib289","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.3390\/antiox9111108","article-title":"Resveratrol improves heart function by moderating inflammatory processes in patients with systolic heart failure","volume":"9","author":"Gal","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jchf.2026.103353_bib290","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99114","article-title":"PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients","volume":"3","author":"Steneberg","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.jchf.2026.103353_bib291","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.005890","article-title":"Brain-derived neurotrophic factor improves impaired fatty acid oxidation via the activation of adenosine monophosphate-activated protein Kinase-\u0251 - proliferator-activated receptor-r coactivator-1\u0251 signaling in skeletal muscle of mice with heart failure","volume":"14","author":"Matsumoto","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib292","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/CIRCULATIONAHA.118.035212","article-title":"Brain-derived neurotrophic factor improves limited exercise capacity in mice with heart failure","volume":"138","author":"Matsumoto","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2026.103353_bib293","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s42003-020-01579-9","article-title":"AdipoR agonist increases insulin sensitivity and exercise endurance in AdipoR-humanized mice","volume":"4","author":"Iwabu","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.jchf.2026.103353_bib294","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.71282","article-title":"Adiponectin receptor agonist AdipoRon improves skeletal muscle function in aged mice","volume":"11","author":"Balasubramanian","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.jchf.2026.103353_bib295","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/jcsm.13148","article-title":"AdipoRon enhances healthspan in middle-aged obese mice: striking alleviation of myosteatosis and muscle degenerative markers","volume":"14","author":"Selvais","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib296","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3390\/cells11101674","article-title":"Metabolomic profiling in patients with heart failure and exercise intolerance: kynurenine as a potential biomarker","volume":"11","author":"Bekfani","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jchf.2026.103353_bib297","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.123.010618","article-title":"Obesity-related biomarkers are associated with exercise intolerance and HFpEF","volume":"16","author":"Ramirez","year":"2023","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2026.103353_bib298","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/bph.15693","article-title":"Butyrate ameliorates skeletal muscle atrophy in diabetic nephropathy by enhancing gut barrier function and FFA2-mediated PI3K\/Akt\/mTOR signals","volume":"179","author":"Tang","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jchf.2026.103353_bib299","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/iub.2539","article-title":"Endogenous dipeptide-carnosine supplementation ameliorates hypobaric hypoxia-induced skeletal muscle loss via attenuating endoplasmic reticulum stress response and maintaining proteostasis","volume":"74","author":"Agrawal","year":"2022","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jchf.2026.103353_bib300","doi-asserted-by":"crossref","first-page":"H1078","DOI":"10.1152\/ajpheart.00679.2014","article-title":"Activation of PPAR\u03b4 signaling improves skeletal muscle oxidative metabolism and endurance function in an animal model of ischemic left ventricular dysfunction","volume":"308","author":"Zizola","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jchf.2026.103353_bib301","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/japplphysiol.00822.2015","article-title":"Pharmacological targeting of mitochondrial reactive oxygen species counteracts diaphragm weakness in chronic heart failure","volume":"120","author":"Laitano","year":"2016","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.jchf.2026.103353_bib302","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/jcsm.12968","article-title":"Targeting MuRF1 by small molecules in a HFpEF rat model improves myocardial diastolic function and skeletal muscle contractility","volume":"13","author":"Adams","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jchf.2026.103353_bib303","article-title":"Trimetazidine and exercise provide comparable improvements to high fat diet-induced muscle dysfunction through enhancement of mitochondrial quality control","volume":"11","author":"Zhang","year":"2021","journal-title":"Sci Rep"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926004567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177926004567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:58:20Z","timestamp":1793649500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177926004567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":303,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2213177926004567"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103353","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal Muscle Dysfunction in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2026.103353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}],"article-number":"103353"}}